Making re-irradiation an option for recurrent head and neck cancer
Patients with recurrent or second primary head and neck cancer who previously received radiation therapy to the head and neck region – especially those with unresectable tumors – have typically had a dismal prognosis and limited treatment options.
Although radiation therapy offers high rates of local disease control, re-irradiating the region is usually avoided for fear of damaging previously irradiated healthy tissue, including...
Proton therapy may help breast cancer patients avoid cardiotoxicity
Radiation therapy to the whole breast or chest wall and the internal mammary lymph nodes can deliver a radiation dose to the heart that increases...
New therapies for follicular lymphoma on the horizon
Recently approved targeted and immunotherapy drugs are helping patients diagnosed with follicular lymphoma live longer. Knowing the available...
Dual procedures offer relief from lymphedema
Cancer patients who have undergone lymph node removal or radiation therapy as part of cancer treatment know all too well the pain and discomfort of lymphedema. The condition occurs when the body, with its missing or damaged lymph nodes, can no longer drain lymph fluid from the arms or legs. Fluid accumulates and chronic swelling occurs.
Typically the condition is managed by drainage-inducing massage, exercise, and compression garments...
Clinical trial tests natural killer cells on pediatric brain tumors
The most common malignant brain tumors in children, medulloblastomas, are usually incurable if they recur. Even with surgery, chemotherapy...
Doctors developing more screenings for cancers related to HPV
The human papillomavirus (HPV) is known to cause a variety of cancers, but screening guidelines and a reliable early-detection test exist...
After stem-cell transplant, re-vaccination is needed
Patients diagnosed with blood-related cancers such as leukemia, lymphoma and multiple myeloma often undergo what is called a hematopoietic...
Vaccine helps T cells target tumors
A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is being investigated...
Turning the immune system against metastatic breast cancer
Although the cure rate for breast cancer has risen steadily in recent decades, recurrent or metastatic disease remains difficult to control...
Concurrent treatment of HIV and cancer improves survival outcomes
Concurrent HIV and cancer present special challenges in the clinic, regardless of which disease is diagnosed first. The simultaneous treatment...